@article{TAU696,
author = {Johannes M. Wolff and Hans-Peter Schmid},
title = {Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab},
journal = {Translational Andrology and Urology},
volume = {1},
number = {2},
year = {2012},
keywords = {},
abstract = {Denosumab is a human monoclonal antibody (IgG2) that binds to RANK ligand (RANKL). It reduces osteoclasts and thereby decreases bone resorption and cancer-induced bone destruction.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/696}
}